Immunologic Deficiency Syndromes: all 702 studies
Page 6 of 8. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.
- Spatial Epidemiology of HIV InfectionCompletedNCT01377272
- Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin TreatmentStatus unknownNCT01359384
- Evaluation of Efficacy and Tolerability of Hizentra®Status unknownNCT01354587Not applicable
- Managerial Database IICompletedNCT01322217
- Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for TuberculosisStatus unknownNCT01315301Not applicable
- Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic CirrhosisCompletedNCT01289951Phase 1
- Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional StudyCompletedNCT01287689
- Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)Status unknownNCT01230580Phase 4
- Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)CompletedNCT01227590Phase 1
- Chinese Network of Pediatric Antiretroviral TherapyCompletedNCT01210924
- A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435CompletedNCT01209117Phase 1
- Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT01200017
- Lymphocyte Immunophenotyping in Common Variable ImmunodeficiencyCompletedNCT01196702
- Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male CircumcisionCompletedNCT01186575Not applicable
- Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 DeficiencyActive, not recruitingNCT01176006Phase 2
- Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1)Status unknownNCT01175239Not applicable
- A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear CellsWithdrawnNCT01173510Phase 4
- Impact of Nutrition Intervention on HIV/AIDS Infected PatientsCompletedNCT01171495Phase 3
- Retrospective Chart Review of Subcutaneous IgG Use in InfantsCompletedNCT01166074
- Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in SwitzerlandStatus unknownNCT01150240
- Study of Vitamin D3 Substitution to Patients With Primary ImmunodeficiencyCompletedNCT01131858Phase 1/2
- Safety of Cotrimoxazole in HIV- and HAART-exposed InfantsCompletedNCT01086878Phase 4
- Fractures Stratified by HIV and Antiretroviral Therapy (ART) StatusCompletedNCT01077557
- HIV Treatment and CVD EventsCompletedNCT01054638
- Medications for Chronic HIV: Education and CollaborationCompletedNCT01038076Not applicable
- Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 InfectionCompletedNCT01032408Phase 3
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant DiseasesCompletedNCT01019876Phase 2/3
- Europe-Africa Research Network for Evaluation of Second-line TherapyCompletedNCT00988039Phase 3
- Pilot Assessment of Lopinavir/Ritonavir and MaravirocTerminatedNCT00981318Phase 4
- The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS PatientsStatus unknownNCT00974519Not applicable
- Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)Status unknownNCT00974454Not applicable
- Mentor Mothers: A Sustainable Family Intervention in South African TownshipsCompletedNCT00972699Phase 2
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMSCompletedNCT00967785Phase 1/2
- CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesCompletedNCT00966160Phase 3
- Computerized HIV/Sexually Transmitted Disease (STD) Prevention ProgramCompletedNCT00947947Phase 2
- An Expanded Safety Study of Dapivirine Gel 4789 in AfricaCompletedNCT00917904Phase 1/2
- An Expanded Safety Study of Dapivirine Gel 4759 in AfricaCompletedNCT00917891Phase 1/2
- Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in KenyaCompletedNCT00914225
- Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIVCompletedNCT00908284Not applicable
- Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS PatientsStatus unknownNCT00872417Phase 4
- Anatomic and Visual Function Assessments on Asymptomatic HIV-positive PatientsCompletedNCT00871078
- Screening Protocol for Genetic Diseases of Allergic InflammationCompletedNCT00852943
- Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk PopulationCompletedNCT00845416
- Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV SubcutaneouslyCompletedNCT00782106Phase 1/2
- Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1TerminatedNCT00781287Phase 4
- Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic LineagesCompletedNCT00758992
- Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, JerusalemStatus unknownNCT00758212Not applicable
- Attitudes and Beliefs and the Steps of HIV CareCompletedNCT00749840
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood CellsCompletedNCT00692926Phase 1
- Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary ImmunodeficiencyCompletedNCT00680446Phase 3
- Reactogenicity and Immunogenicity of Vaginal CNgp140TerminatedNCT00637962Phase 1
- Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency DiseasesStatus unknownNCT00613561Phase 2
- Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIVCompletedNCT00602758Not applicable
- Gene Therapy for ADA-SCIDCompletedNCT00599781Phase 1/2
- Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected PatientsCompletedNCT00551655
- Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)CompletedNCT00551330Phase 2
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)CompletedNCT00523211Phase 3
- Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other ImmunodeficienciesCompletedNCT00517803Not applicable
- Smoking Cessation for HIV/AIDS PatientsCompletedNCT00502827Not applicable
- Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C VirusStatus unknownNCT00499434
- Safety And Efficacy Study Of CP-675,206 In HIV-Infected PatientsWithdrawnNCT00488995Phase 2
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)CompletedNCT00474370Phase 3
- A Clinical Study of Intravenous ImmunoglobulinCompletedNCT00468273Phase 3
- Computer Assisted Rx Education for HIV-Positives: CARE+CompletedNCT00443378Not applicable
- Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected PatientsCompletedNCT00441688Phase 4
- Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load MonitoringCompletedNCT00434070
- Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)CompletedNCT00405184Phase 3
- Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical TrialsCompletedNCT00394004
- Subcutaneous Ig NextGen 16% in PID PatientsCompletedNCT00391131Phase 3
- HIV Prevention in the Primary Care SettingCompletedNCT00381524Not applicable
- A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.CompletedNCT00381212Phase 1/2
- Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From PrisonCompletedNCT00344591Phase 2
- Multidisciplinary Inpatient Palliative Care InterventionCompletedNCT00325611Not applicable
- HIV Prevention Intervention for CouplesCompletedNCT00325585Phase 2
- Examining the Link Between Heart Disease and HIV Infection in WomenCompletedNCT00312468
- Omacor and Cardiovascular Risk Factors in HIV Patients on HAART TreatmentCompletedNCT00296153Phase 4
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution SyndromeCompletedNCT00294918Phase 2/3
- Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)CompletedNCT00294164Phase 2/3
- Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent AdultsCompletedNCT00273988Phase 4
- Longitudinal Study of HAART, Social Networks, & AdherenceCompletedNCT00272220Not applicable
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) TherapyCompletedNCT00270283Phase 2
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) TherapyCompletedNCT00270270Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00270010Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00269945Phase 2
- STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable ImmunodeficiencyCompletedNCT00263237Phase 1
- Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)CompletedNCT00244803
- Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285WithdrawnNCT00243568Phase 3
- The Efficacy of the HIV/AIDS Symptom Management ManualCompletedNCT00241202Not applicable
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell ImmunodeficiencyCompletedNCT00228852Phase 1/2
- Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency PatientsCompletedNCT00220766Phase 3
- Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected SubjectsStatus unknownNCT00172315
- Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)CompletedNCT00168025Phase 3
- Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)CompletedNCT00168012Phase 3
- PI Vs. NNRTI Based Therapy for HIV Advanced DiseaseStatus unknownNCT00162643Phase 4
- Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)CompletedNCT00161993Phase 2
- Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersCompletedNCT00157079Phase 3
- Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency SyndromeCompletedNCT00152100Phase 1
- Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVCompletedNCT00144157Phase 4